“…HPV 5,8,9,12,14,15,17,[19][20][21][22][23][24][25][36][37][38]47,49). [34][35][36] However, a susceptibility locus to EV mapped to chromosome 17qter region, 37 frequent coinfection with HPV 3, 38 and the rarity of EV-like eruptions in immunodeficient states [39][40][41][42][43][44][45][46][47][48][49][50][51][52][53][54][55] indicate that other, nonimmunological factors operate in the development of clinically diagnosable EV infection. None the less, defects of cellmediated immunity such as CD4 lymphopenia in this case, or cutaneous anergy, decreased response to T-cell mitogens (e.g.…”